Hormone Replacement Therapy and Venous Thromboembolism

Abstract

Get full access to this article

View all access options for this article.

References

1. Daly

Vessey

Hawkins

Carson

Gough

Marsh

Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996; 348: 977–80.

2. Grodstein

Stampfer

Goldhaber

Manson

Colditz

Speizer

. Prospective study of exogenous hormones and risk of pulmonary embolism in women. Lancet 1996; 348: 983–7.

3. Jick

Derby

Myers

Vasilakis

Newton

. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens. Lancet 1996; 348: 981–3.

4. Gutthann

Rodriguez

LAG

Castellsague

Oliart

. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study. BMJ 1997; 314: 796–800.

5. Hulley

Grady

Bush

Furberg

Herrington

Riggs

Vittinghoff

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998; 280: 605–13

6. Hormone replacement therapy and venous thromboembolism . Guideline No 19,1999 The Royal College of Obstetricians and Gynaecologists,London, UK